<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03166657</url>
  </required_header>
  <id_info>
    <org_study_id>OHCS</org_study_id>
    <nct_id>NCT03166657</nct_id>
  </id_info>
  <brief_title>Office Hysteroscopy in Secondary Infertility After Cesarean Section</brief_title>
  <official_title>Role of Office Hysteroscopy in Cases of Secondary Infertility After Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All women with history of secondary infertility after caesarean section will be subjected to
      office hysteroscopy according to Royal college of obstetrics and gynecology guidelines to
      diagnose any subtle uterine abnormalities not detected by conventional means.

      Hysteroscopic examination will be done during the proliferation phase of the menstrual cycle.

      The hysteroscopic evaluation will include assessment of the cervical canal, intrauterine
      lesions, the endometrium and the uterotubal junction. .

      If hysteroscopy reveal a lesion, its type, size, location will be recorded. Transvaginal
      ultrasound will be done after the procedure to detect fluid in the douglas pouch to confirm
      patent tubes.

      Asses the uterine scar in details.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">June 1, 2019</completion_date>
  <primary_completion_date type="Actual">June 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of patients with abnormal scar findings in hysteroscopy</measure>
    <time_frame>1 year</time_frame>
    <description>color of the scar and presence of niche</description>
  </primary_outcome>
  <enrollment type="Actual">56</enrollment>
  <condition>Infertility, Female</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>office hysteroscopy</intervention_name>
    <description>A speculum is first inserted into the vagina. The hysteroscope is then inserted and gently moved through the cervix into uterus. Carbon dioxide gas or a fluid, such as saline will be put through the hysteroscope into uterus to expand it. The gas or fluid helps see the lining more clearly. The amount of fluid used is carefully checked throughout the procedure</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study will include all secondary infertile cases after cesarean section who presented
        to infertility clinic at Women health Hospital, Assiut University
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with secondary infertility more than 2 years after cesarean section.

          -  Normal semen analysis

          -  Normal hysterosalpingography or laparoscopy within 1year

          -  Evidence of ovulation by transvaginal ultrasound

        Exclusion Criteria:

          -  â€¢ Cases with abnormal semen parameters.

               -  Patients with abnormal hysterosalpingography.

               -  Patients with anovulation.

               -  Hormonal disturbances; high level of prolactin, thyroid hormone disturbances,
                  very high or very low follicular stimulating hormone and luteinizing hormone

               -  Patients known to be epileptic or with history of fits.

               -  Cardiac patients ( valve diseases, ischemic, arrhythmic)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Women Health Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod. 2007 Jun;22(6):1506-12. Epub 2007 Mar 21. Erratum in: Hum Reprod. 2007 Oct;22(10):2800.</citation>
    <PMID>17376819</PMID>
  </reference>
  <reference>
    <citation>Collins JA, Crosignani PG. Unexplained infertility: a review of diagnosis, prognosis, treatment efficacy and management. Int J Gynaecol Obstet. 1992 Dec;39(4):267-75. Review.</citation>
    <PMID>1361459</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 24, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>May 10, 2020</last_update_submitted>
  <last_update_submitted_qc>May 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ayman Ahmad Abdelraof Ahmad Askar</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

